Which is the preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment? Full Text
Cardiovascular Diabetology,

Mallat SG – Clinical studies suggest that in CV high–risk patients and those with evidence of renal disease, the use of an ARB/CCB combination may be preferred to ARB/HCTZ combinations due to superior renoprotective and CV benefits and reduced metabolic side effects in patients with concomitant metabolic disorders. However, selection of the most appropriate antihypertensive combination should be dependent on careful review of the individual patient and appropriate consideration of drug pharmacology.

  • Hypertension is a major associated risk for organ damage and mortality, which is further heightened in patients with prior cardiovascular (CV) events, comorbid diabetes mellitus, microalbuminuria and renal impairment.
  • Given that most patients with hypertension require at least two antihypertensives to achieve blood pressure (BP) goals, identifying the most appropriate combination regimen based on individual risk factors and comorbidities is important for risk management.
  • Single–pill combinations (SPCs) containing two or more antihypertensive agents with complementary mechanisms of action offer potential advantages over free–drug combinations, including simplification of treatment regimens, convenience and reduced costs.
  • The improved adherence and convenience resulting from SPC use is recognised in updated hypertension guidelines.
  • Despite a wide choice of SPCs for hypertension treatment, clinical evidence from direct head–to–head comparisons to guide selection for individual patients is lacking.
  • However, in patients with evidence of renal disease or at greater risk of developing renal disease, such as those with diabetes mellitus, microalbuminuria and high–normal BP or overt hypertension, guidelines recommend renin–angiotensin system (RAS) blocker–based combination therapy due to superior renoprotective effects compared with other antihypertensive classes.
  • Furthermore, RAS inhibitors attenuate the oedema and renal hyperfiltration associated with calcium channel blocker (CCB) monotherapy, making them a good choice for combination therapy.
  • The occurrence of angiotensin–converting enzyme (ACE) inhibitor–induced cough supports the use of angiotensin II receptor blockers (ARBs) for RAS blockade rather than ACE inhibitors.
  • In this regard, ARB–based SPCs are available in combination with the diuretic, hydrochlorothiazide (HCTZ) or the calcium CCB, amlodipine.
  • Telmisartan, a long–acting ARB with preferential pharmacodynamic profile compared with several other ARBs, and the only ARB with an indication for the prevention of CV disease progression, is available in two SPC formulations, telmisartan/HCTZ and telmisartan/amlodipine.

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Ophthalmology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Ophthalmology Articles

1 Mini-monovision versus multifocal intraocular lens implantation Journal of Cataract & Refractive Surgery, October 8, 2014    Clinical Article

2 Femtosecond laser-assisted cataract surgery versus standard phacoemulsification cataract surgery: Outcomes and safety in more than 4000 cases at a single center Journal of Cataract & Refractive Surgery, November 17, 2014    Clinical Article

3 Original and generic latanoprost for the treatment of glaucoma and ocular hypertension: are they really the same? Clinical and Experimental Pharmacology and Physiology, October 29, 2014    Clinical Article

4 Comparison of outcomes of primary anterior chamber versus secondary scleral-fixated intraocular lens implantation in complicated cataract surgeries American Journal of Ophthalmology, November 7, 2014    Clinical Article

5 What we know about ocular manifestations of Ebola Full Text Clinical Ophthalmology, November 26, 2014    Free full text    Clinical Article

6 Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: Prospective placebo-controlled randomised study British Journal of Ophthalmology, November 25, 2014    Clinical Article

7 Stem cell therapy for glaucoma: Science or snake oil? Survey of Ophthalmology, November 3, 2014    Review Article

8 Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma Survey of Ophthalmology, November 4, 2014    Evidence Based Medicine    Review Article

9 Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension Annals of Pharmacotherapy, November 14, 2014    Review Article

10 An evaluation of cataract surgery clinical practice guidelines British Journal of Ophthalmology, November 5, 2014    Clinical Guideline    Clinical Article

11 Relationship between systemic hypertension, perfusion pressure and glaucoma: A comparative study in an adult Indian population Full Text Indian Journal of Ophthalmology, November 21, 2014    Free full text    Clinical Article

12 The diurnal and nocturnal effects of travoprost in normal-tension glaucoma Full Text Clinical Ophthalmology, November 18, 2014    Free full text    Clinical Article

13 Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications Full Text Therapeutics and Clinical Risk Management, September 10, 2014    Free full text    Clinical Article

14 Associations between primary open angle glaucoma, Alzheimer's disease and vascular dementia: Record linkage study British Journal of Ophthalmology, November 24, 2014    Clinical Article

15 Signs of ALS detected in the eye Northwestern Medicine News, October 24, 2014

16 Exogenous fungal endophthalmitis: An analysis of isolates and susceptibilities to antifungal agents over a 20 year period (1990-2010) American Journal of Ophthalmology, November 20, 2014    Clinical Article

17 Twice-daily brinzolamide/brimonidine fixed combination versus brinzolamide or brimonidine in open-angle glaucoma or ocular hypertension Ophthalmology, October 31, 2014    Clinical Article

18 Advanced imaging for glaucoma study: Design, baseline characteristics, and inter-site comparison American Journal of Ophthalmology, November 12, 2014    Clinical Article

19 Long-term results of non-valved Glaucoma drainage implant surgery and glaucoma drainage implant combined with trabeculectomy Full Text Indian Journal of Ophthalmology, November 10, 2014    Free full text    Clinical Article

20 Comparative analysis of the visual performance after cataract surgery with implantation of a bifocal or trifocal diffractive IOL Journal of Refractive Surgery, October 27, 2014    Clinical Article

Indexed Journals in Ophthalmology: American Journal of Ophthalmology, Retina, Eye, Corneamore